US4996193A
(en)
*
|
1989-03-03 |
1991-02-26 |
The Regents Of The University Of California |
Combined topical and systemic method of administration of cyclosporine
|
US5540931A
(en)
*
|
1989-03-03 |
1996-07-30 |
Charles W. Hewitt |
Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
|
CA1340994C
(en)
*
|
1989-09-21 |
2000-05-16 |
Rudolf Edgar Dr. Falk |
Treatment of conditions and disease
|
ZA927277B
(en)
*
|
1991-10-02 |
1993-05-19 |
Boston Ocular Res |
Dry eye treatment process and solution.
|
DE69307505T2
(de)
|
1992-05-13 |
1997-07-24 |
Sandoz Ag |
Opthalmische zusammensetzungen enthaltend ein cyclosporin
|
US5366739A
(en)
*
|
1992-08-06 |
1994-11-22 |
Deo Corporation |
Method of ophthalmic drug delivery
|
US5830508A
(en)
|
1992-08-06 |
1998-11-03 |
Deo Corporation |
Composition for treating dry eye
|
US5686436A
(en)
|
1993-05-13 |
1997-11-11 |
Hiv Diagnostics, Inc. |
Multi-faceted method to repress reproduction of latent viruses in humans and animals
|
US5474979A
(en)
*
|
1994-05-17 |
1995-12-12 |
Allergan, Inc. |
Nonirritating emulsions for sensitive tissue
|
IE75744B1
(en)
*
|
1995-04-03 |
1997-09-24 |
Elan Corp Plc |
Controlled release biodegradable micro- and nanospheres containing cyclosporin
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
US5858401A
(en)
*
|
1996-01-22 |
1999-01-12 |
Sidmak Laboratories, Inc. |
Pharmaceutical composition for cyclosporines
|
PT888127E
(pt)
|
1996-02-13 |
2002-05-31 |
Searle & Co |
Combinacoes tendo efeitos imunossupresores contendo inibidores de cilcooxigenase-2 e inibidores de 5-lipoxigenase
|
EP0880363B1
(en)
|
1996-02-13 |
2002-09-11 |
G.D. SEARLE & CO. |
Combinations, having immunosuppressive effects, containing a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor
|
JP2000506170A
(ja)
*
|
1996-03-05 |
2000-05-23 |
メデイノックス,インコーポレイテッド |
酸化窒素スキャベンジャーを用いる複合治療方法とそのために有用な組成物
|
US20030220234A1
(en)
*
|
1998-11-02 |
2003-11-27 |
Selvaraj Naicker |
Deuterated cyclosporine analogs and their use as immunodulating agents
|
NZ502362A
(en)
|
1997-10-08 |
2001-05-25 |
Isotechnika Inc |
Deuterated cyclosporine A derivatives and their use as immunomodulating agents
|
US6861411B1
(en)
|
1997-12-02 |
2005-03-01 |
Pfizer, Inc. |
Method of treating eye infections with azithromycin
|
US5981607A
(en)
*
|
1998-01-20 |
1999-11-09 |
Allergan |
Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers
|
GB9818278D0
(en)
*
|
1998-08-22 |
1998-10-14 |
Smith & Nephew |
Compositions
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US6217895B1
(en)
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US7056893B2
(en)
|
1999-03-31 |
2006-06-06 |
Insite Vision, Inc. |
Topical treatment for prevention of ocular infections
|
US6239113B1
(en)
|
1999-03-31 |
2001-05-29 |
Insite Vision, Incorporated |
Topical treatment or prevention of ocular infections
|
US6255280B1
(en)
|
1999-04-08 |
2001-07-03 |
University Of Kentucky Research Foundation |
Protection against traumatic brain injury
|
US6254860B1
(en)
*
|
1999-04-13 |
2001-07-03 |
Allergan Sales, Inc. |
Ocular treatment using cyclosporin-A derivatives
|
ES2309410T5
(es)
|
1999-10-15 |
2015-03-17 |
Sucampo Ag |
Nueva composición que contiene un compuesto bi-ciclico y un glicérido
|
PT1142566E
(pt)
|
2000-04-07 |
2004-02-27 |
Medidom Lab |
Formulacao oftalmica topica na forma de uma solucao aquosa e uso de uma ciclosporina em associacao com acido hialuronico ou um de seus sais e com polisorbato 80
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
WO2002098376A1
(en)
*
|
2001-06-06 |
2002-12-12 |
The Regents Of The University Of Michigan |
Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enyzmes
|
ES2326040T3
(es)
|
2001-10-19 |
2009-09-29 |
Isotechnika Inc. |
Sintesis de analogos de ciclosporina.
|
KR20030065831A
(ko)
*
|
2002-02-01 |
2003-08-09 |
주식회사 태평양 |
사이클로스포린을 함유한 지속 방출형 약학적 조성물
|
US8871241B2
(en)
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
US6930127B2
(en)
*
|
2002-08-15 |
2005-08-16 |
Eaton Veterinary Laboratories, Inc. |
Veterinary treatment of ophthalmic disease in animals using topical tacrolimus
|
US7354574B2
(en)
|
2002-11-07 |
2008-04-08 |
Advanced Ocular Systems Limited |
Treatment of ocular disease
|
EP1603512A2
(en)
*
|
2003-03-17 |
2005-12-14 |
Albany Molecular Research, Inc. |
Novel cyclosporins
|
US20040185068A1
(en)
*
|
2003-03-18 |
2004-09-23 |
Zhi-Jian Yu |
Self-emulsifying compositions, methods of use and preparation
|
CA2520660C
(en)
*
|
2003-03-28 |
2013-08-20 |
Sigmoid Biotechnologies Limited |
Solid oral dosage form containing seamless microcapsules
|
US7083802B2
(en)
|
2003-07-31 |
2006-08-01 |
Advanced Ocular Systems Limited |
Treatment of ocular disease
|
US20050059583A1
(en)
|
2003-09-15 |
2005-03-17 |
Allergan, Inc. |
Methods of providing therapeutic effects using cyclosporin components
|
US7087237B2
(en)
*
|
2003-09-19 |
2006-08-08 |
Advanced Ocular Systems Limited |
Ocular solutions
|
US7083803B2
(en)
|
2003-09-19 |
2006-08-01 |
Advanced Ocular Systems Limited |
Ocular solutions
|
DE602005011928D1
(de)
|
2004-01-20 |
2009-02-05 |
Allergan Inc |
Zusammensetzungen für die lokalisierte therapie des auges, vorzugsweise enthaltend triamcinolon-acetonid und hyaluronsäure
|
US7923471B2
(en)
*
|
2004-05-14 |
2011-04-12 |
Alcon, Inc. |
Method of treating dry eye disorders and uveitis
|
US20050277584A1
(en)
*
|
2004-06-09 |
2005-12-15 |
Allergan, Inc. |
Pharmaceutical compositions comprising cyclosporins
|
PL1811979T3
(pl)
*
|
2004-09-27 |
2009-04-30 |
Sigmoid Pharma Ltd |
Mikrokapsułki zawierające metyloksantynę i kortykosteroid
|
EP1809656A4
(en)
*
|
2004-09-29 |
2009-03-25 |
Amr Technology Inc |
CYCLOSPORINAL KINANALOGA AND ITS PHARMACEUTICAL APPLICATIONS
|
US7511013B2
(en)
*
|
2004-09-29 |
2009-03-31 |
Amr Technology, Inc. |
Cyclosporin analogues and their pharmaceutical uses
|
JP2008515886A
(ja)
*
|
2004-10-06 |
2008-05-15 |
エーエムアール テクノロジー インコーポレイテッド |
シクロスポリンアルキンおよびそれらの医用薬剤としての有用性
|
US7151085B2
(en)
*
|
2004-11-15 |
2006-12-19 |
Allergan, Inc. |
Therapeutic methods using cyclosporine components
|
US7135455B2
(en)
*
|
2004-11-15 |
2006-11-14 |
Allergan, Inc |
Methods for the therapeutic use of cyclosporine components
|
WO2006073786A2
(en)
*
|
2004-12-30 |
2006-07-13 |
Bausch & Lomb Incorporated |
Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy
|
SI1848431T1
(sl)
|
2005-02-09 |
2016-05-31 |
Santen Pharmaceutical Co., Ltd. |
Tekoče formulacije za zdravljenje bolezni ali stanj
|
US20070014760A1
(en)
*
|
2005-07-18 |
2007-01-18 |
Peyman Gholam A |
Enhanced recovery following ocular surgery
|
WO2007011880A2
(en)
|
2005-07-18 |
2007-01-25 |
Minu, L.L.C. |
Enhanced ocular neuroprotection/neurostimulation
|
CA2625700A1
(en)
*
|
2005-10-14 |
2007-04-26 |
Allergan, Inc. |
Prevention and treatment of drug-associated ocular side effects with a cyclosporin
|
US9839667B2
(en)
|
2005-10-14 |
2017-12-12 |
Allergan, Inc. |
Prevention and treatment of ocular side effects with a cyclosporin
|
US7745400B2
(en)
*
|
2005-10-14 |
2010-06-29 |
Gregg Feinerman |
Prevention and treatment of ocular side effects with a cyclosporin
|
US8067433B2
(en)
*
|
2005-11-09 |
2011-11-29 |
Zalicus Inc. |
Methods, compositions, and kits for the treatment of ophthalmic disorders
|
JP5528708B2
(ja)
|
2006-02-09 |
2014-06-25 |
参天製薬株式会社 |
安定な製剤ならびにそれらを調製および使用する方法
|
US7655625B2
(en)
*
|
2006-02-13 |
2010-02-02 |
Allergan, Inc. |
Methods of treating blepharospasm using cyclosporine components
|
US7557082B2
(en)
|
2006-03-03 |
2009-07-07 |
Allergan, Inc. |
Treatment with cyclosporin A
|
US20070219127A1
(en)
*
|
2006-03-20 |
2007-09-20 |
Walt John G |
Cyclosporin a compositions
|
US8222271B2
(en)
|
2006-03-23 |
2012-07-17 |
Santen Pharmaceutical Co., Ltd. |
Formulations and methods for vascular permeability-related diseases or conditions
|
US7696166B2
(en)
*
|
2006-03-28 |
2010-04-13 |
Albany Molecular Research, Inc. |
Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
|
US7696165B2
(en)
*
|
2006-03-28 |
2010-04-13 |
Albany Molecular Research, Inc. |
Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
|
US20080146497A1
(en)
*
|
2006-07-25 |
2008-06-19 |
Graham Richard S |
Cyclosporin Compositions
|
EP2380564B1
(en)
*
|
2007-04-04 |
2014-10-22 |
Sigmoid Pharma Limited |
An oral pharmaceutical composition
|
US20100144609A1
(en)
*
|
2007-05-04 |
2010-06-10 |
Donnenfeld Eric D |
Methods using cyclosporin in treating patients with intraocular lenses
|
US20090081277A1
(en)
*
|
2007-09-21 |
2009-03-26 |
Allergan, Inc. |
Pharmaceutical formulations and methods for treating ocular conditions
|
WO2009048929A1
(en)
|
2007-10-08 |
2009-04-16 |
Lux Biosciences, Inc. |
Ophthalmic compositions comprising calcineurin inhibitors or mtor inhibitors
|
ITMI20080003A1
(it)
*
|
2008-01-02 |
2009-07-03 |
Alfredo Pulpito |
Composizioni per uso oftalmico
|
US20100010082A1
(en)
*
|
2008-07-09 |
2010-01-14 |
Aspreva International Ltd. |
Formulations for treating eye disorders
|
US9445975B2
(en)
*
|
2008-10-03 |
2016-09-20 |
Access Business Group International, Llc |
Composition and method for preparing stable unilamellar liposomal suspension
|
NZ593770A
(en)
|
2009-01-08 |
2013-12-20 |
Allergan Inc |
Compositions for enhancing nail growth
|
US20110009339A1
(en)
*
|
2009-04-14 |
2011-01-13 |
Allergan, Inc |
Method of treating blurred vision and other conditions of the eye with cyclosporin compositions
|
GB2483815B
(en)
|
2009-05-18 |
2013-12-25 |
Sigmoid Pharma Ltd |
Composition comprising oil drops
|
CA2764802A1
(en)
|
2009-06-05 |
2010-12-09 |
Allergan, Inc. |
Artificial tears and therapeutic uses
|
MX338355B
(es)
*
|
2009-06-09 |
2016-04-13 |
Aurinia Pharmaceuticals Inc |
Sistemas de suministro de farmaco topico para uso oftalmico.
|
EP2464341B1
(en)
|
2009-08-12 |
2022-07-06 |
Sublimity Therapeutics Limited |
Immunomodulatory compositions comprising a polymer matrix and an oil phase
|
EP2335735A1
(en)
|
2009-12-14 |
2011-06-22 |
Novaliq GmbH |
Pharmaceutical composition for treatment of dry eye syndrome
|
CN102740830A
(zh)
*
|
2009-12-23 |
2012-10-17 |
普西维达公司 |
缓释递送装置
|
GB201020032D0
(en)
|
2010-11-25 |
2011-01-12 |
Sigmoid Pharma Ltd |
Composition
|
US8957048B2
(en)
|
2011-10-06 |
2015-02-17 |
Allergan, Inc. |
Compositions for the treatment of dry eye
|
ES2578154T3
(es)
|
2011-11-15 |
2016-07-21 |
Allergan, Inc. |
Forma 2 de ciclosporina y método para prepararla
|
KR102015152B1
(ko)
|
2011-11-15 |
2019-08-27 |
알러간, 인코포레이티드 |
사이클로스포린 a 제2형의 현탁액
|
BR112014011744A2
(pt)
|
2011-11-15 |
2017-05-02 |
Allergan Inc |
formulação de ação sustentável da forma 2 de ciclosporina
|
US9907826B2
(en)
|
2011-12-07 |
2018-03-06 |
Allergan, Inc. |
Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
|
US20130266615A1
(en)
*
|
2012-04-10 |
2013-10-10 |
Bin Wu |
Non-immunogenic delivery vehicle for beta-, gamma-, and delta-tocopherols and methods of using and making same
|
CA2871070C
(en)
*
|
2012-04-20 |
2024-01-02 |
Howard University |
Method of treating an ocular disease and compositions effective for treating an ocular disease
|
GB201212010D0
(en)
|
2012-07-05 |
2012-08-22 |
Sigmoid Pharma Ltd |
Formulations
|
GB201319791D0
(en)
|
2013-11-08 |
2013-12-25 |
Sigmoid Pharma Ltd |
Formulations
|
PT3215127T
(pt)
|
2014-11-07 |
2021-02-10 |
Sublimity Therapeutics Ltd |
Composições que compreendem ciclosporina
|
MX2017006474A
(es)
|
2014-11-25 |
2017-09-12 |
Allergan Inc |
Composiciones oftalmicas estabilizadas de omega 3.
|
US9820954B2
(en)
|
2015-08-19 |
2017-11-21 |
Jenivision Inc. |
Quantitative peri-orbital application of ophthalmology drugs
|
US20190224275A1
(en)
|
2017-05-12 |
2019-07-25 |
Aurinia Pharmaceuticals Inc. |
Protocol for treatment of lupus nephritis
|